Effect of dose schedule of vitamin E and hydroxethylruticide on intestinal toxicity induced by adriamycin.
CDF1 mice receiving Adriamycin, 12 mg/kg IP develop a toxic GI mucositis. The mean survival in CDF1 mice after Adriamycin injection was found to be 6.5 +/- 2.0 weeks and could be increased by alcohol or acetate Vitamin E pretreatment (with 2 g/kg qDx7d) to 22.06 +/- 12.3 weeks or by treatment with Venoruton after Adriamycin (qDx7 with 1.5 g/kg) to 23.7 +/- 12.7 weeks. Other schedules were ineffective or harmful. The ability of Venoruton to enhance survival when given after Adriamycin encouraged us to proceed to tumor bearing mice. The maximum survival with CDF1 mice bearing 5 X 10(6) L1210 cells was 1 +/- 0.2 week which could be increased to 2.17 +/- 0.8 weeks with optimal dose Adriamycin (10 mg/kg). Optimum survival with Venoruton and a single dose of Adriamycin was 2.45 +/- 0.91 weeks with Venoruton, 1.5 g, qd X 14, and 12 mg/kg Adriamycin. Treatment of L1210 bearing mice with Adriamycin, 10 mg/kg on days 1 and 8, yielded a survival of 2.23 +/- 0.7 weeks. An equitoxic regimen of Adriamycin, 11 mg/kg on days 1 and 9, plus Venoruton, 1.5 g, qd X 14, increased survival 30% to 3.08 +/- 2.9 weeks. Venoruton is a promising agent to increase the therapeutic index of Adriamycin.
D000818:Animals; D004317:Doxorubicin / Q000633:toxicity*; D006896:Hydroxyethylrutoside / Q000494:pharmacology*; D007410:Intestinal Diseases / Q000139:chemically induced* / Q000473:pathology; D007422:Intestines / Q000473:pathology; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D012431:Rutin / Q000031:analogs & derivatives*; D014815:Vitamins / Q000494:pharmacology*
D006896:Hydroxyethylrutoside; D014815:Vitamins; D012431:Rutin; D004317:Doxorubicin